EXACT SCIENCES CORP's ticker is and the CUSIP is 30063PAC9. A total of 56 filers reported holding EXACT SCIENCES CORP in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,554,776 | +643.1% | 2,960,000 | +781.0% | 0.00% | – |
| Q2 2023 | $343,788 | +16.5% | 336,000 | 0.0% | 0.00% | – |
| Q1 2023 | $295,038 | +12.0% | 336,000 | 0.0% | 0.00% | – |
| Q4 2022 | $263,357 | -89.1% | 336,000 | -91.2% | 0.00% | -100.0% |
| Q3 2022 | $2,419,000 | -46.7% | 3,824,000 | -42.1% | 0.00% | -66.7% |
| Q2 2022 | $4,539,000 | -69.2% | 6,607,000 | -60.6% | 0.00% | -57.1% |
| Q1 2022 | $14,739,000 | -0.8% | 16,768,000 | +8.9% | 0.01% | 0.0% |
| Q4 2021 | $14,865,000 | -44.5% | 15,394,000 | -38.3% | 0.01% | -46.2% |
| Q3 2021 | $26,774,000 | +5.7% | 24,939,000 | +21.7% | 0.01% | +8.3% |
| Q2 2021 | $25,341,000 | +4.0% | 20,498,000 | +8.5% | 0.01% | -7.7% |
| Q1 2021 | $24,378,000 | +1.4% | 18,898,000 | +2.3% | 0.01% | -13.3% |
| Q4 2020 | $24,044,000 | +33.3% | 18,481,000 | +10.7% | 0.02% | +25.0% |
| Q3 2020 | $18,032,000 | +79.7% | 16,700,000 | +59.0% | 0.01% | +50.0% |
| Q2 2020 | $10,035,000 | – | 10,500,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LINDEN ADVISORS LP | 404,000,000 | $317,894,000 | 5.65% |
| ARISTEIA CAPITAL, L.L.C. | 60,500,000 | $47,768,000 | 4.03% |
| Myriad Asset Management Ltd. | 16,000,000 | $12,680,000 | 1.90% |
| Ionic Capital Management LLC | 2,500,000 | $1,980,000 | 1.61% |
| BlueCrest Capital Management Ltd | 26,350,000 | $20,764,000 | 1.43% |
| CAMDEN ASSET MANAGEMENT L P /CA | 53,500,000 | $41,974,000 | 1.24% |
| Nicholas Investment Partners, LP | 7,000,000 | $5,492,000 | 1.07% |
| Cheyne Capital Management (UK) LLP | 1,175,000 | $926,000 | 0.95% |
| CQS (US), LLC | 15,780,000 | $12,453,000 | 0.92% |
| ZAZOVE ASSOCIATES LLC | 7,110,000 | $5,644,000 | 0.68% |